A fatal outcome from SARS-CoV-2 infection: One case report of a young man with multiple organ damage

Yingting Zeng1, Xiaoyue Zhou2, Yadong Gang1

  • 1Department of Radiology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, China.

Radiology of Infectious Diseases (Beijing, China)
|February 1, 2021
PubMed

Insights

This case study highlights how coronavirus disease 2019 (COVID-19) can cause severe systemic inflammation and rapid organ damage, leading to acute respiratory distress syndrome (ARDS). It emphasizes the critical condition progression in some COVID-19 patients.

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Pathology

Background:

  • Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, emerged globally in late 2019.
  • A previously healthy 36-year-old male presented with persistent fever, weakness, and diarrhea.

Observation:

  • The patient tested positive for SARS-CoV-2.
  • Laboratory results indicated systemic inflammation and multi-organ damage.
  • Chest radiographs showed dynamic lung lesions consistent with clinical deterioration.

Findings:

  • The patient rapidly progressed to severe acute respiratory distress syndrome (ARDS).
  • Systemic inflammation and multi-organ damage, particularly pancreatic damage, were observed.
  • The patient died on hospital day 13.

Implications:

  • SARS-CoV-2 infection can trigger severe inflammatory responses and multi-organ damage.
  • COVID-19 patients can experience rapid clinical deterioration, especially when critically ill.
  • Close monitoring and understanding of inflammatory markers are crucial for managing severe COVID-19 cases.

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
594
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
744
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
147
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
1.8K
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
566
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
518